ArticleCureus2026
Crohn's Disease Developing After Hirschsprung's Disease in a Child With Down Syndrome: A Rare Clinical Overlap.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We describe a rare pediatric case of an eight-year-old boy with Down syndrome who developed Hirschsprung's disease in the neonatal period and was later diagnosed with Crohn's disease, representing an exceptionally uncommon clinical overlap. The patient experienced a complex clinical course marked by necrotizing enterocolitis, intestinal perforation, multiple abdominal surgeries, and persistent gastrointestinal dysfunction from infancy. Despite definitive surgical management of Hirschsprung's disease, he continued to have chronic diarrhea, malabsorption, failure to thrive, and recurrent inflammatory symptoms. Further evaluation revealed markedly elevated fecal calprotectin levels and endoscopic evidence of erosive-ulcerative colitis with pseudopolyps. Radiologic, endoscopic, and histologic findings ultimately confirmed a diagnosis of Crohn's disease with ileocolonic involvement and a recurrent disease course. Initial treatment with corticosteroids and immunomodulators resulted in only partial and transient responses, and therapy was complicated by drug-induced renal impairment. The patient was subsequently escalated to biologic therapy with infliximab, achieving partial control of intestinal inflammation, alongside ongoing nutritional support with a peptide-based enteral formula. This case underscores the diagnostic and therapeutic challenges of inflammatory bowel disease in children with Down syndrome and prior Hirschsprung's disease, in whom postoperative complications and chronic enterocolitis may obscure the diagnosis. It highlights the importance of maintaining a high index of suspicion for Crohn's disease in this population and emphasizes the need for long-term surveillance and a multidisciplinary approach to management in children with complex congenital and inflammatory gastrointestinal disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.